Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
iSTAR Medical's MINIject maintains exceptional results in first-in-human trial one year post-surgery (STAR-I)
2018-12-19 16:00
Bridge Biotherapeutics Signs US$40M License Agreement with Daewoong Pharmaceutical for Co-development of UC Drug Candidate
2018-12-19 08:00
Ajinomoto and XL-protein Forge Strategic Alliance to Develop PASylated Therapeutics Applying the Corynex® Platform
2018-12-18 23:00
Artificial Intelligence Is Propelling the Pharmaceutical Industry by Enabling Smart Drug Discovery Solutions
2018-12-17 21:50
NeuClone Announces its Sixth Biosimilar Candidate Perjeta(R) (Pertuzumab) for use in Combination Therapy with Herceptin(R) (Trastuzumab)
2018-12-17 21:30
I-Mab and CSPC Pharma Announce Strategic Partnership for Long-acting GLP-1 Fc Program
2018-12-17 19:10
PharmaEssentia and AOP Orphan Receive Positive CHMP Opinion For Besremi(™) (Ropeginterferon alfa-2b) For Treatment Of Polycythemia Vera (PV) In EU
2018-12-17 16:00
Innovate and Win the Future through Intelligence, P-MEC China 2019 to "Set Sail" Intelligently
2018-12-17 15:00
China Biologic Announces Dismissal of Lawsuit Filed in Cayman Islands by Former Chairman
2018-12-14 21:00
bioLIVE China 2019 to be Newly Upgraded to Lead the Development of Bio-Pharma Technology in Asia
2018-12-14 15:00
With the Chinese API Market Growing, CPhI China Assists Enterprises with Transformation, Innovation, and Comprehensive Upgrading
2018-12-13 15:00
WuXi AppTec Lists H Shares on the Hong Kong Stock Exchange
2018-12-13 10:23
Innovent Announces Two Clinical Studies with the Anti-VEGF Monoclonal Antibody IBI305, a Biosimilar Candidate to Avastin (Bevacizumab), Met Primary Endpoints
2018-12-13 08:00
WuXi Biologics Congratulates Tychan on First-in-Class Monoclonal Antibody for Yellow Fever after Record 7 Months of Development
2018-12-13 07:30
Grasp Changing Trends and Seek Industry Prosperity: InnoPack China 2019 to Create Room for Innovation with Every Effort
2018-12-12 15:00
Luye Pharma's Global Strategy For CNS-Focused Products Gathers Pace: Rotigotine Extended Release Microspheres Submitted to Japan's PMDA for Clinical Trial Approval
2018-12-12 13:53
Mayne Pharma receives FDA approval of Tolsura™ (SUBA®-itraconazole capsules) for the treatment of certain fungal infections
2018-12-12 07:05
The Menarini Group Announces Meropenem/vaborbactam European Marketing Authorization
2018-12-12 01:42
Cerecin Sponsors and Presents at Alzheimer's Disease Therapeutics: Alternatives to Amyloid Symposium
2018-12-11 16:05
Mundipharma to distribute Norspan(R) in Japan
2018-12-11 15:36
1
338
339
340
341
342
410